Citation Impact
Citing Papers
Effects Of a One-Month Treatment With PTH(1–34) on Bone Formation on Cancellous, Endocortical, and Periosteal Surfaces of the Human Ilium
2007
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research
2015
European guidance for the diagnosis and management of osteoporosis in postmenopausal women
2012 Standout
Clinician’s Guide to Prevention and Treatment of Osteoporosis
2014 Standout
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Bone regeneration: current concepts and future directions
2011 Standout
The Role of Tumor Necrosis Factor α in Down-Regulation of Osteoblast Phex Gene Expression in Experimental Murine Colitis
2006
Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis
2011
Osteoporosis
2019 Standout
Identification of a Vitamin D response element in the human insulin receptor gene promoter
2003
Guidelines on Urolithiasis<footref rid="foot01"><sup>1</sup></footref>
2001 Standout
Urinary inhibitors of calcium oxalate crystallization and their potential role in stone formation
1997
Emerging therapeutic opportunities for skeletal restoration
2011
Sunlight and Vitamin D
2013 Standout
An essential role for Rxrα in the development of Th2 responses
2005 StandoutNobel
Impracticability of Informed Consent in the Registry of the Canadian Stroke Network
2004 Standout
Joint Official Positions of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX®
2011
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Evaluation of urine composition and calcium salt crystallization properties in standardized volume-adjusted 12-h night urine from normal subjects and calcium oxalate stone formers
1997
Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International Workshop
2014
Relationship between bone mineral density and biochemical markers of bone turnover in hemodialysis patients
2007
Remodelling the extracellular matrix in development and disease
2014 Standout
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
Sarcopenia
2019 Standout
Annual change in bone mineral density in predialysis patients with chronic renal failure: significance of a decrease in serum 1,25-dihydroxy-vitamin D
2006
Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 1: Hip Geometry
2015
Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study
2001
Targeting TGFβ signaling in subchondral bone and articular cartilage homeostasis
2014
Management of severe osteoporosis
2015
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Emerging therapeutic concepts for muscle and bone preservation/building
2015
Role of urinary inhibitors of crystallization in uric acid nephrolithiasis: Dalmatian dog model
2003
The role and efficacy of denosumab in the treatment of osteoporosis: an update
2011
Quantitative imaging techniques for the assessment of osteoporosis and sarcopenia
2018
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
2002 Standout
10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension
2017
Chronic Kidney Disease
2016 Standout
Denosumab and bisphosphonates: Different mechanisms of action and effects
2010
Prevention of Osteoporosis in Heart Transplant Recipients: A Comparison of Calcitriol with Calcitonin and Pamidronate
2000
Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis
2014
The Role of Vitamin D and Calcium in Type 2 Diabetes. A Systematic Review and Meta-Analysis
2007 Standout
Capturing Magnesium Ions via Microfluidic Hydrogel Microspheres for Promoting Cancellous Bone Regeneration
2021 Standout
Medical Management of Kidney Stones: AUA Guideline
2014 Standout
Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS study
2009
Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab
2015
The Nuclear Vitamin D Receptor: Biological and Molecular Regulatory Properties Revealed
1998
Modulators of urinary stone formation
2004
Vitamin D and Immune Function
2013 Standout
Opportunistic Screening for Osteoporosis Using Abdominal Computed Tomography Scans Obtained for Other Indications
2013
25-Hydroxyvitamin D Deficiency and Diabetes Predict Reduced BMD in Patients With Chronic Kidney Disease
2006
Denosumab Reduces Cortical Porosity of the Proximal Femoral Shaft in Postmenopausal Women With Osteoporosis
2016
Postmenopausal osteoporosis treatment with antiresorptives: Effects of discontinuation or long-term continuation on bone turnover and fracture risk—a perspective
2012
Kidney Stone Disease: An Update on Current Concepts
2018 Standout
Assessment of Melamine and Cyanuric Acid Toxicity in Cats
2007 Standout
Cortical PQCT Measures Are Associated With Fractures in Dialysis Patients
2006
American Association of Oral and Maxillofacial Surgeons Position Paper on Medication-Related Osteonecrosis of the Jaw—2014 Update
2014 Standout
FEA to Measure Bone Strength: A Review
2016
The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism
2016 Standout
Works of César E. Bogado being referenced
Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate
2010
Bone densitometry in a patient with hypophosphatemic osteomalacia
2004
Clinical Use of Quantitative Computed Tomography and Peripheral Quantitative Computed Tomography in the Management of Osteoporosis in Adults: The 2007 ISCD Official Positions
2008
Evaluation of Cortical Bone by Peripheral Quantitative Computed Tomography in Renal Transplant Recipients
2005
Effects of teriparatide [rhPTH (1–34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women
2005
Denosumab: An update
2011
DNA Sequences Downstream from the Vitamin D Response Element of the Rat Osteocalcin Gene Are Required for Ligand-Dependent Transactivation
1997
Glycosaminoglycans in Urolithiasis
1992
Differing effects of denosumab and alendronate on cortical and trabecular bone
2013
Osteoporosis following heart transplantation.
1996
Multicenter precision of cortical and trabecular bone quality measures assessed by high-resolution peripheral quantitative computed tomography
2012
Treatment of postmenopausal women with osteoporosis with PTH(1–84) for 36 months: treatment extension study
2010
Bone Mineral Density: Serum Markers of Bone Turnover and Their Relationships in Peritoneal Dialysis
2004
EVALUATION OF CORTICAL BONE BY PERIPHERAL QUANTITATIVE COMPUTED TOMOGRAPHY (PQCT) IN RENAL TRANSPLANT (TX) PATIENTS
2004